CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: April-09-13
Credit Expiration Date: April-09-14


Steven Berney, MD
Professor Emeritus, Medicine
Temple University School of Medicine
Section of Rheumatology
Philadelphia, PA

Credit Hours

Physicians: 0.75 AMA PRA Category 1 CreditTM


Online Presentation

Program Description

Psoriatic arthritis (PsA) is a chronic inflammatory arthropathy that is usually associated with psoriasis and usually seronegative for rheumatoid factor. In the United States, prevalence estimates in the general population range from 0.1% to 0.25%; a lack of widely accepted diagnostic criteria makes more accurate estimates difficult. Rheumatoid arthritis (RA) is a chronic inflammatory disease that causes joint pain, stiffness, and swelling, and increases the risk of systemic conditions such as cardiovascular disease. RA currently affects 1.3 million people in the United States, and the incidence of RA is on the rise in women.

Rheumatologists and other clinicians involved in the management of PsA and RA have the opportunity to improve outcomes in patients with these conditions by expanding their knowledge and skills. The goal of this continuing education activity is to increase the awareness of rheumatologists and other clinicians involved in the management of PsA and RA to implement the latest clinical evidence related to diagnosis and treatment.

In this online presentation, faculty will discuss information presented at ACR 2012 on diagnosis, imaging, and treatment of PsA and RA.

Target Audience

Rheumatologists, nurse practitioners, physician assistants, and other health care clinicians interested and involved in the treatment of patients with PsA and RA.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Compare clinical manifestations of PsA with those of RA, osteoarthritis, and other inflammatory joint diseases.
  2. Discuss the emerging data on imaging in the diagnosis and monitoring of PsA and RA.
  3. Discuss the limitations of using RA assessment criteria for the assessment of PsA treatment.
  4. Review the findings of selected current trials for PsA and RA treatment.


It is the policy of Temple University School of Medicine; The Albert J. Finestone, MD Office for Continuing Medical Education to insure balance, independence, objectivity, and scientific rigor in all of its sponsored or jointly sponsored educational programs. All faculty, program planning committee members, and Temple University School of Medicine Continuing Medical Education staff participating in programs sponsored or jointly sponsored by Temple University School of Medicine are expected to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation(s).

Planning committee members have no financial relationships to disclose.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, Temple University School of Medicine, Temple University Health System or its affiliates. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Dr. Berney has no relevant financial relationships to disclose.

Credit Statements

Accreditation Statement: Temple University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor Continuing Medical Education for physicians.

Certification Statement: Temple University School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

There is no fee to participate and receive credit.

Credit Provider Contact Information
Temple University
School of Medicine
The Albert J. Finestone, MD Office for CME
3500 North Broad Street Philadelphia, PA 19140
Phone: 215-707-4787
Fax: 215-707-8268

Commercial Support Statements

This activity is supported through an independent educational grant from Celgene Corporation.

This activity is supported through an independent educational grant from Amgen Inc.


Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers

  1. Please turn off all pop-up blockers to assure access to the educational activity.
  2. Click on the "Start program" icon at the bottom of this page. You may start as a GUEST, but to claim credit, you must be a member. If you are not already registered as a user of this website, visit the login/registration page where you will be able to register as a new member or check existing registration information.
  3. The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. The activity will take approximately 45 minutes to complete.
  4. After the program has finished, click on the "Post-test" button.
  5. Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen. A credit statement/certificate will be awarded for a score of 65% or better and may be printed immediately after passing the post-test.

Certificate Fee



Copyright © 2013. Temple University School of Medicine. All rights reserved.

Presented by Temple University School of Medicine and MCM Education.

The opinions expressed in these educational activities are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Temple University School of Medicine, Celgene or Amgen Inc. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

To view our privacy policies, please visit:

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu